StockLearn from Clustermicro · Stock Breakout ScannerStockLearn

Glottis Limited (GLOTTIS)

Healthcare Equipment · NSE · end-of-day 2026-10-19
Close
₹54.39
Day change
-2.98%
1-year
-34.3%
From 52-week high
-33.5%
Weinstein stage
Stage 1
Minervini template
3/8
Glottis Limited closed at ₹54.39 on 2026-10-19, down 34% over the past year, 34% below its 52-week high. It meets 3 of 8 conditions of Minervini's trend template; Weinstein's stage analysis reads stage 1 - basing. Over the year its annualised volatility was about 47%, with a largest fall of 54% from a peak.

About Glottis Limited

Glottis Limited provides logistics and technology-enabled freight-forwarding services supporting international trade and supply-chain operations. Its platform connects customers with transportation and logistics services across global markets. Growth in international trade and increasing demand for technology-enabled logistics provide long-term opportunities. Digitalization and network expansion can improve operating efficiency. Freight rates, global trade volumes, fuel costs, working capital, customer concentration, and competition remain important factors.

Price, RSI and MACD

Price · -3.1% over the period
5358626771Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
RSI (14) · 39.2
305070
MACD (12, 26, 9) · histogram -0.22
-2.6-0.81.12.94.7
Price · -33.5% over the period
3648607284Oct 25Dec 25Feb 26Apr 26Jun 26Aug 26Oct 26
RSI (14) · 39.2
305070
MACD (12, 26, 9) · histogram -0.22
-4.6-2.20.12.54.9
Price: daily close adjusted for splits and bonuses, dashed line the 150-day moving average. MACD: green line, orange dashed signal, bars the histogram. Longer periods are drawn from every second or third session.

Fundamentals

Market capSales (TTM)Net profit (TTM)P/EEPS (TTM)P/BROEDebt / equityFree cash flowEV / EBITDABeta
₹503 cr——13.44.151.7913.7%0.18₹-79 cr9.90.98

Quarterly results

QuarterSales ₹ crNet profit ₹ crEPSEPS YoYSales YoYNet margin
Dec 202514430.29——1.9%
Sep 2025383243.04——6.3%
Jun 2025168121.49——7.1%
Standalone · EPS restated onto today's share count after splits and bonuses · net profit as filed.

Minervini SEPA — earnings checks 0 of 0 pass

CheckResult
Latest quarter EPS up 25%+ on a year ago— Not assessable
EPS growth accelerating over 3 quarters— Not assessable
Sales up 25%+, or sales growth accelerating— Not assessable
Annual EPS up 25%+ in each of the last 2 years— Not assessable
Net margin above the same quarter last year— Not assessable

Investor methods

MethodChecksScoreVerdict
Minervini
✗ Close above the 150- and 200-day averages
✓ 150-day above 200-day
✗ 200-day rising for a month
✓ 50-day above the 150- and 200-day
✗ Close above the 50-day
✓ At least 25% above the 52-week low · low 38.14
✗ Within 25% of the 52-week high · high 81.81
✗ RS percentile 70 or more · RS 15
Trend template - the gate, measured: a modest 21-day edge.
3/83 of 8
Weinstein
Stan Weinstein's stage analysis on the 30-week moving average.
Stage 1 - basing
CAN SLIM
— C latest quarter EPS up 25%+
— A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held
✗ N within 15% of the 52-week high · high 81.81
✓ S more volume on up days than down days (50 sessions) · 1.13x
✗ L RS percentile 80 or more · RS 15
— I institutional sponsorship rising · shareholding not collected yet
✓ M market in an uptrend (40%+ of stocks above their 200-day) · breadth 45%
William O'Neil's growth-leader checklist.
2/4Average
Turtle
✗ Close above the prior 55-session high · 70.25
✗ Close above the prior 20-session high · 69.72
✗ Close below the prior 20-session low · 53.44
Donchian channel breakout - the Turtle traders' entry.
No signal
Graham
✗ Price at or below the Graham number · Graham number 53.27
✓ P/E 15 or less · P/E 13.1
✗ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 1.79
✓ Current ratio 2 or more · 3.81
— 10 years of positive earnings, 20 of dividends · history not held
Benjamin Graham's defensive-investor tests.
98/100Fair
Each method's own rules applied to this stock - information, not a buy or sell signal. All were tested on 2024-26 data; only the Minervini trend template showed a consistent edge.

Healthcare Equipment sector — top 10 by 1-year return

Stock1M %3M %6M %1Y %3Y %5Y %P/EP/BROE %ROCE %ROA %D/EEV/EBITDA₹ CrSales TTM ₹ CrProfit TTM ₹ CrEPSBeta
GLOTTIS this stock-8.6-17.8-3.1-23.9——13.41.7913.7——0.189.9503——4.20.98
SHAILY-1.4+8.7+68.2+30.0+747.9—65.519.9326.929.3—0.2450.214,2841,27121847.40.51
TARSONS+3.0+12.1+48.2+8.4-36.2—150.82.642.34.5—0.6015.11,677441112.11.15
NURECA-9.4+10.9+20.7+8.3-13.6-82.861.31.651.13.3—0.0036.929918755.11.07
MOHEALTH-6.6-5.1+10.5+6.8+68.5————————————0.58
POLYMED-10.2-9.9+6.5-18.6+12.4+64.449.95.0611.013.7—0.1129.615,7181,99731331.10.91
AMRUTANJAN+1.1-8.7-8.3-30.8-16.9-46.426.73.9016.622.4—0.0017.51,4435125418.70.51
LAXMIDENTL-8.2-18.9-6.0-42.1——32.14.1112.813.1—0.0021.8999287315.71.19
A blank in a return column means the stock is younger than that window. P/B and ROE come from each company's own filings where held.

Healthcare Equipment stocks of a similar size

Nureca LimitedLaxmi Dental LimitedAmrutanjanTarsons Products LimitedShailyPoly MedicureMohealth
The live scanner - every stock ranked, filtered by method, stage and sector, with interactive charts - is in the StockLearn app. Open the StockLearn scanner →
Prices as of 2026-10-19, end of day, from NSE. Fundamentals from each company's own exchange filings (XBRL), EPS restated for splits and bonuses. Figures may be delayed and are for information only.
For research & education only — not investment advice. The methods, checks and verdicts are automated rules applied to public data, not buy/sell recommendations. StockLearn is an independent product of ClusterMicro Technologies, not affiliated with or endorsed by the NSE or any exchange. ClusterMicro Technologies is not a SEBI-registered investment adviser. Consult a SEBI-registered adviser before investing.